Sofinnova Ventures »

Glaukos shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Glaukos (GKOS) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Glaukos

Tip: Access up to 7 years of quarterly data

All positions including Glaukos held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glaukos by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2025-09-30 $26M 313k 81.55

More positions owned by Sofinnova Ventures

Natera (NTRA)
Gilead Sciences (GILD)
United Therapeutics Corporation Put Option (UTHR)
Vera Therapeutics Cl A (VERA)
Jazz Pharmaceuticals Shs Usd (JAZZ)
AstraZeneca Sponsored Adr (AZN)
Rapport Therapeutics (RAPP)
Boston Scientific Corporation (BSX)
Uniqure NV SHS Call Option (QURE)
Dex (DXCM)
Intuitive Surgical (ISRG)
Axsome Therapeutics (AXSM)
Roivant Sciences SHS (ROIV)
iShares TR Ishares Biotech Put Option (IBB)
Vertex Pharmaceuticals Incorporated (VRTX)

View all positions for Sofinnova Ventures

Top funds holding Glaukos

BlackRock
Vanguard Group
Wellington Management Company
PRIMECAP Management Company
State Street Corporation
Ameriprise Financial
Alliancebernstein
Geode Capital Management
Westfield Capital Management Company
William Blair Investment Management
Henderson Group
Millennium Management
Capital World Investors
Braidwell
Brown Capital Management

View all funds holding Glaukos